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CASE REPORT
Recurrent bacteremia after injection 
of N-butyl-2-cyanoacrylate for treatment 
of bleeding gastric varices: a case report 
and review of the literature
Bruno A. Randi1*, Daniel A. Ninomiya1, Elizabeth L. Nicodemo1, Beatriz C. Lopes2, Eduardo R. Cançado2 
and Anna S. Levin1
Abstract 
Background: Bleeding from gastric varices has high mortality rate, and obliteration using N-butyl-2-cyanoacrylate is 
the treatment of choice. Recurrent bacteremia is rarely reported following the procedure. We aimed to report a case 
of recurrent bacteremia after N-butyl-2-cyanoacrylate treatment and to review published cases.
Case presentation and review: In May 2014, a 43-year-old Brazilian male presented with lower gastrointestinal 
bleeding. Endoscopy showed active bleeding from gastric varix. Injection of N-butyl-2-cyanoacrylate was performed 
and the patient was discharged. Over the next 4 months he presented with three episodes of bacteremia with severe 
sepsis and no identifiable focus of infection. Oral prophylaxis was initiated in September 2014 and he has remained 
free of bacteremia. Six other cases of recurrent bacteremia following sclerosis with N-butyl-2-cyanoacrylate were 
reported in the literature. All patients had portal hypertension and bleeding from gastric varices. Average age of 
patients was 55.7 years and the median time from endoscopic procedure to the first episode of bacteremia was 
105 days (range 14–365). The mean number of episodes of bacteremia per patient was 2.5.
Conclusion: Recurrent bacteremia associated with endoscopic treatment with N-2-butyl-cyanoacrylate is rare, but 
should be suspected in patients in which investigation shows no other focus of infection. Secondary prophylaxis 
should be considered after the first episode.
Keywords: Cyanoacrylates, Esophageal and gastric varices, Bacteremia, Liver cirrhosis
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Background
Prevalence of gastric varices in patients with portal 
hypertension varies from 18 to 70  % [1]. Bleeding from 
gastric varices has a mortality rate of 45 % [1]. There are 
many treatment options for bleeding gastric varices and, 
although limited data exist on optimal management, 
the first-line treatment advocated is endoscopic oblit-
eration using N-butyl-2-cyanoacrylate. This liquid glue 
polymerizes immediately into a plastic cast after contact 
with blood [2, 3].
Bacteremia after endoscopic procedures may occur in 
a frequency of 4.2 %, and can be higher in patients with 
chronic liver disease and in therapeutic procedures [3]. 
Transient bacteremia following injection of cyanoacr-
ylate is not uncommon [2], but recurrent bacteremia is 
rarely reported. We aimed to report a case of recurrent 
bacteremia after N-butyl-2-cyanoacrylate treatment and 
to review the literature for published cases.
Case report
A 43-year-old Brazilian male was under follow-up at the 
gastroenterology outpatient clinic due to autoimmune 
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hepatitis-associated liver cirrhosis (Child-Pugh class A/
MELD 13). He had portal hypertension and diabetes mel-
litus and used azathioprine (100 mg/day) and prednisone 
(10  mg/day). He presented at our emergency depart-
ment with lower gastrointestinal bleeding in May 2014. 
Upper endoscopy showed active bleeding from a gastric 
varix. Hemostasis was achieved by injection of N-butyl-
2-cyanoacrylate and the patient was discharged 3  days 
after admission, using propranolol. In July 2014, the 
patient returned to our hospital with a history of 7 days 
of fever (up to 40 °C) associated with tachycardia (cardiac 
rate: 110 beats/min) and hypotension (blood pressure: 
80/50  mmHg). There was no headache, nausea, vomit-
ing, diarrhea, abdominal pain, cough, urinary symptoms 
or bleeding. The patient was admitted to the intensive 
care unit and ceftriaxone 2  g/day and vasoactive drugs 
were initiated. Chest radiography and urine exams were 
normal, and abdomen-CT did not show signs of abscess 
or ascitis. His blood culture grew Streptococcus angi-
nosus, only resistant to clindamycin and erythromycin. 
The antibiotic was continued for 7  days and the patient 
quickly improved and was discharged. In August 2014, he 
returned presenting only fever. His blood culture revealed 
group C beta-hemolytic Streptococcus, only resistant 
to clindamycin and erythromycin, and Escherichia coli 
susceptible to all antibiotics tested. Full abdomen-CT, 
chest-CT, transesophageal ecochardiography, colonos-
copy and a positron emission tomography did not show 
any signs of infection. Upper digestive endoscopy did not 
show any complications at the site of the cyanoacrylate 
injection. The patient was treated for 4 weeks of IV ceftri-
axone and discharged. In September 2014, he returned, 
presenting with severe sepsis and blood cultures positive 
for Enterococcus faecalis susceptible to ampicillin and E. 
coli susceptible to multiple antibiotics. An abdominal CT 
was performed and a radio-opaque material was detected 
within the perigastric and cardiophrenic varicose veins 
corresponding to cyanoacrylate embolization. Ampicil-
lin (12  g per day) and ceftriaxone were maintained for 
4  weeks. Due to the recurrent episodes of bacteremia, 
the patient was discharged using of amoxicillin–clavu-
lanate (500/125  mg) three times-a-day on a continuous 
basis. Since then, the patient remains free of episodes of 
bacteremia.
Literature review
Besides the present case, six other cases of recurrent 
bacteremia following variceal sclerosis with N-butyl-
2-cyanoacrylate were reported in the English language 
literature. The characteristics of the seven cases are 
shown in Table  1 [2, 4, 6, 14]. All patients had portal 
hypertension and the indication of injection of cyanoacr-
ylate was bleeding from gastric varices.
The average age of the patients was 55.7 years and the 
median time from the endoscopic procedure to the first 
episode of bacteremia was 105 days (range 14–365). The 
average number of episodes of bacteremia per patient 
was 2.5.
All cases, after extensive investigation, showed no other 
focus of infection. In one patient, the same microorgan-
ism from the blood culture grew from the cyanoacrylate 
thrombus after a specimen was collected using endos-
copy [2].
Discussion
N-butyl-2-cyanoacrylate is a liquid glue that can be used 
in several types of human and veterinary procedures, 
such as patch fixation for hernia repair [7], uterine artery 
embolization for leiomyomas and placenta increta [8], 
treatment of renal arteriovenous malformation [9] and 
for obliteration of gastric varices [1–6, 10–14]. Recur-
rent bacteremia has been described only for this last 
procedure.
Around 90 % of patients develop transient fever after 
N-butyl-2-cyanoacrylate injection [14], however the 
incidence of bacteremia after the procedure is not clear. 
Chen et  al. observed that the frequency of bactere-
mia in the cyanoacrylate group was higher than in the 
group under upper endoscopy without cyanoacrylate 
injection (15/47 vs. 1/47, p < 0.0001) [11]. Furthermore, 
high volume of blood transfusion and Child-Pugh score 
were factors associated with the occurrence of bacte-
remia [11]. Jun et al. observed a frequency of 0.4 % of 
bacteremia and a Brazilian study did not showed differ-
ences in incidence of bacteremia between band ligation 
and cyanoacrylate injection [3]. A prospective study 
with 55 patients only reported bacteremia after injec-
tion for treatment of bleeding gastric varices. Elective 
cyanoacrylate injection for nonbleeding gastric varices 
was not associated with any episodes of bacteremia 
[13].
Recurrent bacteremia, however, is a very rare event 
with only seven cases described. All patients reported 
underwent cyanoacrylate treatment for bleeding gastric 
varices. Because of the rarity of the condition, recurrent 
bacteremia associated with injection of cyanoacrylate 
should be a diagnosis of exclusion and other more com-
mon diagnoses, such as spontaneous bacterial peritonitis, 
must be investigated. New diagnostic tools, such as F-18 
FDG PET/CT, may be useful in the diagnosis of infected 
cyanoacrylate plug [12], but require more studies.
In six of the reported cases including this one, compli-
cations associated with cyanoacrylate, such as abscess [4] 
or embolism [4, 6], were found. Two cases of persistent 
(but not recurrent) bacteremia reported showed incom-
plete obliteration of gastric varices, possibly facilitating 
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bacterial translocation. In these cases, fever subsided 
after total obliteration [5].
Most recurrent episodes of bacteremia were caused by 
the same microorganism [2, 4, 6], except for the present 
report and one other [14], in which multiple bacteria 
were implicated. All the microorganisms isolated from 
blood cultures in all reports were commensals from the 
oral or gastrointestinal flora. Thus, migration of bacte-
ria from the gastrointestinal lumen to blood vessels was 
probably facilitated by the cyanoacrylate plug. Polym-
erization of cyanoacrylate has been described to form a 
large conglomerate that may protrude intraluminally and 
provide an ideal route for bacterial invasion [10, 14].
We believe that after an episode of bacteremia fol-
lowing the injection of N-butyl-2-cyanoacrylate for the 
treatment of bleeding gastric varices, in which there is 
no evidence of the source of infection, long term second-
ary prophylaxis with antimicrobials should be considered 
due to the gravity of these bloodstream infections.
In conclusion, recurrent bacteremia associated with 
previous endoscopic treatment with N-2-butyl-cyanoacr-
ylate is very rare, but should be suspected in patients in 
which extensive investigation fails to show another focus 
of infection. Complications associated with cyanoacr-
ylate must be ruled out. Secondary prophylaxis should 
be considered in these patients after the first episode of 
bacteremia.
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